The Effect of Long-acting Antipsychotics on Schizophrenia Patients With Violence Risk

Huazhong University of Science and Technology

Status: Unknown

Conditions: Schizophrenia

Treatments: Drug: Paliperidone Palmitate

Study type: Observational

Funder types: Other

Identifiers

NCT04064476

WG17A002II

Details and patient eligibility

About

This is a 49 weeks prospective, non-interventional cohort study. To observe the effect of long-acting injection antipsychotic(LAI), paliperidone palmitate on prevention of recurrence and symptom control in schizophrenia patients with violence risk. This study can be extended according to the implementation of the project and extended follow-up time.

Full description

This is a 49 weeks prospective, observational cohort study. Wuhan initiated a project to improve the LAI treatment in schizophrenia patient with violence risk. This observational study will build the cohort of schizophrenia patient with violence risk and treated with LAI paliperidone palmitate. The effect of long-acting antipsychotic, paliperidone palmitate, will be observed on prevention of recurrence and symptom control in these patients. safety information and laboratory tests result will also be collected. This study can be extended according to the implementation of the project and extended follow-up time.

Enrollment: 225 estimated patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Patient who has violence risk and in the supervise of government system, and treated with paliperidone palmitate will be invited to the observational study.